Oral isotretinoin for acne: a complete overview.
Isotretinoin
acne
acne scars
severe acne
treatment
Journal
Expert opinion on drug safety
ISSN: 1744-764X
Titre abrégé: Expert Opin Drug Saf
Pays: England
ID NLM: 101163027
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
pubmed:
20
7
2022
medline:
8
9
2022
entrez:
19
7
2022
Statut:
ppublish
Résumé
Acne is one of the most common and widespread skin conditions, affecting the health as much as patients' quality of life. A wide variety of treatments for acne, topical and systemics, could be prescribed, depending on its degree of severity. Isotretinoin, a derivative of retinol, has been widely used for the treatment of severe forms of acne and those forms not responding to conventional treatments. In literature, there are several studies describing its efficacy, also reporting side-effects related to the drug; therefore, this has led the scientific community to request further studies qualifying its characteristics and comparing its efficacy and safety with other classic acne treatments, as well as with different treatment regimes, in order to find the dose with the best efficacy/safety ratio. The aim of this article is to provide a complete overview on the use of oral isotretinoin for the treatment of acne describing the efficacy, safety, and tolerability of the drug. Oral isotretinoin represents a valid therapeutic alternative in treating severe and mild-to-moderate acne lesions, also reducing scarring damage. There are no standardized protocols regarding the use of oral isotretinoin and its association with other therapies; however, the correct patient selection and a tailored treatment protocol according to acne lesions severity and type should be considered in order to obtain optimal results.
Identifiants
pubmed: 35852102
doi: 10.1080/14740338.2022.2102605
doi:
Substances chimiques
Dermatologic Agents
0
Isotretinoin
EH28UP18IF
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM